Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

Carbon Nanotubes and Carbon Nanotube Structures Used for Temperature Measurement.

Monea BF, Ionete EI, Spiridon SI, Ion-Ebrasu D, Petre AE.

Sensors (Basel). 2019 May 29;19(11). pii: E2464. doi: 10.3390/s19112464. Review.

2.

Impact of hospital pharmacist interventions on the combination of citalopram or escitalopram with other QT-prolonging drugs.

Chastang A, Renet S, Corny J, Beaussier H, Petre A, Lillo-Lelouet A, Phan Thi TT, Bézie Y.

Int J Clin Pharm. 2019 Feb;41(1):42-48. doi: 10.1007/s11096-018-0724-7. Epub 2019 Jan 4.

PMID:
30610545
3.

Virtual facebow technique using standardized background images.

Petre A, Drafta S, Stefanescu C, Oancea L.

J Prosthet Dent. 2019 May;121(5):724-728. doi: 10.1016/j.prosdent.2018.07.008. Epub 2018 Dec 21.

PMID:
30580985
4.

[Opportunities and challenges of blockchain technology in the healthcare industry].

Petre A, Haï N.

Med Sci (Paris). 2018 Oct;34(10):852-856. doi: 10.1051/medsci/2018204. Epub 2018 Nov 19. Review. French.

5.

Carboplatin in combination with weekly Paclitaxel as first-line therapy in patients with recurrent/metastatic head and neck squamous cell carcinoma unfit to EXTREME schedule.

Pêtre A, Dalban C, Karabajakian A, Neidhardt EM, Roux PE, Poupart M, Deneuve S, Zrounba P, Fayette J.

Oncotarget. 2018 Apr 24;9(31):22038-22046. doi: 10.18632/oncotarget.25157. eCollection 2018 Apr 24.

6.

A bacterium-based contact assay for evaluating the quality of solid samples-Results from an international ring-test.

Marques CR, El-Azhari N, Martin-Laurent F, Pandard P, Meline C, Petre AL, Eckert S, Zipperle J, Váňa M, Maly S, Šindelářová L, Amemori AS, Hofman J, Kumar A, Doan H, McLaughlin M, Richter E, Römbke J.

J Hazard Mater. 2018 Jun 15;352:139-147. doi: 10.1016/j.jhazmat.2018.03.022. Epub 2018 Mar 20.

PMID:
29604511
7.

Survival Rates and Complications for Zirconia-Based Fixed Dental Prostheses in a Period up to 10 Years: A Systematic Review.

Stefanescu C, Ionita C, Nechita V, Drafta S, Oancea L, Petre A.

Eur J Prosthodont Restor Dent. 2018 May 30;26(2):54-61. doi: 10.1922/EJPRD_01681Stefanescu08. Review.

PMID:
29517875
8.

Vogt-Koyanagi-Harada-like Syndrome Complicating Pembrolizumab Treatment for Metastatic Melanoma.

Bricout M, Petre A, Amini-Adle M, Bezza W, Seve P, Kodjikian L, Dalle S, Thomas L.

J Immunother. 2017 Feb/Mar;40(2):77-82. doi: 10.1097/CJI.0000000000000154.

PMID:
28166182
9.

El sindrome depresivo melancólico en el infancia.

Gareiso A, Sagreras PO, Petre A.

Arch Argent Pediatr. 2015 Jun;113(3):e175-96. Spanish. No abstract available.

PMID:
26221645
10.

Impact of preoperative use of P2Y12 receptor inhibitors on clinical outcomes in cardiac and non-cardiac surgery: A systematic review and meta-analysis.

Siller-Matula JM, Petre A, Delle-Karth G, Huber K, Ay C, Lordkipanidzé M, De Caterina R, Kolh P, Mahla E, Gersh BJ.

Eur Heart J Acute Cardiovasc Care. 2017 Dec;6(8):753-770. doi: 10.1177/2048872615585516. Epub 2015 May 5. Review.

PMID:
25943554
11.

Space charge distributions in insulating polymers: A new non-contacting way of measurement.

Marty-Dessus D, Ziani AC, Petre A, Berquez L.

Rev Sci Instrum. 2015 Apr;86(4):043905. doi: 10.1063/1.4919008.

PMID:
25933869
12.

AMS analyses of I-129 from the Fukushima Daiichi nuclear accident in the Pacific Ocean waters of the Coast La Jolla--San Diego, USA.

Stan-Sion C, Enachescu M, Petre AR.

Environ Sci Process Impacts. 2015 May;17(5):932-8. doi: 10.1039/c5em00124b. Epub 2015 Apr 22.

PMID:
25901961
13.

Continuous ozonation treatment of ofloxacin: transformation products, water matrix effect and aquatic toxicity.

Carbajo JB, Petre AL, Rosal R, Herrera S, Letón P, García-Calvo E, Fernández-Alba AR, Perdigón-Melón JA.

J Hazard Mater. 2015 Jul 15;292:34-43. doi: 10.1016/j.jhazmat.2015.02.075. Epub 2015 Feb 28.

PMID:
25796038
14.

Personal care product preservatives: risk assessment and mixture toxicities with an industrial wastewater.

Carbajo JB, Perdigón-Melón JA, Petre AL, Rosal R, Letón P, García-Calvo E.

Water Res. 2015 Apr 1;72:174-85. doi: 10.1016/j.watres.2014.12.040. Epub 2014 Dec 30.

PMID:
25585550
15.

Osteotome-mediated sinus floor elevation: a systematic review and meta-analysis.

Călin C, Petre A, Drafta S.

Int J Oral Maxillofac Implants. 2014 May-Jun;29(3):558-76. doi: 10.11607/jomi.3206. Review.

PMID:
24818194
16.

Treatment of a wastewater from a pesticide manufacture by combined coagulation and Fenton oxidation.

Pliego G, Zazo JA, Pariente MI, Rodríguez I, Petre AL, Leton P, García J.

Environ Sci Pollut Res Int. 2014 Nov;21(21):12129-34. doi: 10.1007/s11356-014-2880-1. Epub 2014 Apr 26.

PMID:
24764009
17.

Novel method for proliferation of oral keratinocyte stem cells.

Calenic B, Paun IA, van Staden RI, Didilescu A, Petre A, Dinescu M, Greabu M.

J Periodontal Res. 2014 Dec;49(6):711-8. doi: 10.1111/jre.12153. Epub 2013 Dec 11.

PMID:
24329011
18.

Autoproteolytic fragments are intermediates in the oligomerization/aggregation of the Parkinson's disease protein alpha-synuclein as revealed by ion mobility mass spectrometry.

Vlad C, Lindner K, Karreman C, Schildknecht S, Leist M, Tomczyk N, Rontree J, Langridge J, Danzer K, Ciossek T, Petre A, Gross ML, Hengerer B, Przybylski M.

Chembiochem. 2011 Dec 16;12(18):2740-4. doi: 10.1002/cbic.201100569. Epub 2011 Nov 7.

19.

[Pathogenesis of thrombotic and hemorrhagic complications in myeloproliferative and myelodysplastic syndromes].

Vlădăreanu AM, Popov V, Bumbea H, Ciufu C, Vasilache V, Petre A, Onisâi M.

Rev Med Chir Soc Med Nat Iasi. 2011 Jan-Mar;115(1):14-9. Romanian.

PMID:
21688554
20.

Ecotoxicological assessment of surfactants in the aquatic environment: combined toxicity of docusate sodium with chlorinated pollutants.

Rosal R, Rodea-Palomares I, Boltes K, Fernández-Piñas F, Leganés F, Petre A.

Chemosphere. 2010 Sep;81(2):288-93. doi: 10.1016/j.chemosphere.2010.05.050. Epub 2010 Jun 25.

PMID:
20579683
21.

Coagulation-Fenton coupled treatment for ecotoxicity reduction in highly polluted industrial wastewater.

Perdigón-Melón JA, Carbajo JB, Petre AL, Rosal R, García-Calvo E.

J Hazard Mater. 2010 Sep 15;181(1-3):127-32. doi: 10.1016/j.jhazmat.2010.04.104. Epub 2010 May 2.

PMID:
20537462
22.

Intraepithelial p63-dependent expression of distinct components of cell adhesion complexes in normal esophageal mucosa and squamous cell carcinoma.

Thépot A, Hautefeuille A, Cros MP, Abedi-Ardekani B, Pétré A, Damour O, Krutovskikh V, Hainaut P.

Int J Cancer. 2010 Nov 1;127(9):2051-62. doi: 10.1002/ijc.25221.

23.

Application of the combination index (CI)-isobologram equation to study the toxicological interactions of lipid regulators in two aquatic bioluminescent organisms.

Rodea-Palomares I, Petre AL, Boltes K, Leganés F, Perdigón-Melón JA, Rosal R, Fernández-Piñas F.

Water Res. 2010 Jan;44(2):427-38. doi: 10.1016/j.watres.2009.07.026. Epub 2009 Jul 25.

PMID:
19683324
24.

Occurrence of emerging pollutants in urban wastewater and their removal through biological treatment followed by ozonation.

Rosal R, Rodríguez A, Perdigón-Melón JA, Petre A, García-Calvo E, Gómez MJ, Agüera A, Fernández-Alba AR.

Water Res. 2010 Jan;44(2):578-88. doi: 10.1016/j.watres.2009.07.004. Epub 2009 Jul 9.

PMID:
19628245
25.

Ecotoxicity assessment of lipid regulators in water and biologically treated wastewater using three aquatic organisms.

Rosal R, Rodea-Palomares I, Boltes K, Fernández-Piñas F, Leganés F, Gonzalo S, Petre A.

Environ Sci Pollut Res Int. 2010 Jan;17(1):135-44. doi: 10.1007/s11356-009-0137-1. Epub 2009 Mar 31.

PMID:
19333638
26.

Elaboration of the preliminary Rheumatoid Arthritis Impact of Disease (RAID) score: a EULAR initiative.

Gossec L, Dougados M, Rincheval N, Balanescu A, Boumpas DT, Canadelo S, Carmona L, Daurès JP, de Wit M, Dijkmans BA, Englbrecht M, Gunendi Z, Heiberg T, Kirwan JR, Mola EM, Matucci-Cerinic M, Otsa K, Schett G, Sokka T, Wells GA, Aanerud GJ, Celano A, Dudkin A, Hernandez C, Koutsogianni K, Akca FN, Petre AM, Richards P, Scholte-Voshaar M, Von Krause G, Kvien TK.

Ann Rheum Dis. 2009 Nov;68(11):1680-5. doi: 10.1136/ard.2008.100271. Epub 2008 Dec 3.

PMID:
19054825
27.

Degradation of caffeine and identification of the transformation products generated by ozonation.

Rosal R, Rodríguez A, Perdigón-Melón JA, Petre A, García-Calvo E, Gómez MJ, Agüera A, Fernández-Alba AR.

Chemosphere. 2009 Feb;74(6):825-31. doi: 10.1016/j.chemosphere.2008.10.010. Epub 2008 Nov 25.

PMID:
19036403
28.

Recent advances in p53 research: an interdisciplinary perspective.

Olivier M, Petitjean A, Marcel V, Pétré A, Mounawar M, Plymoth A, de Fromentel CC, Hainaut P.

Cancer Gene Ther. 2009 Jan;16(1):1-12. doi: 10.1038/cgt.2008.69. Epub 2008 Sep 19. Review.

PMID:
18802452
29.

Post-translational tyrosine nitration of eosinophil granule toxins mediated by eosinophil peroxidase.

Ulrich M, Petre A, Youhnovski N, Prömm F, Schirle M, Schumm M, Pero RS, Doyle A, Checkel J, Kita H, Thiyagarajan N, Acharya KR, Schmid-Grendelmeier P, Simon HU, Schwarz H, Tsutsui M, Shimokawa H, Bellon G, Lee JJ, Przybylski M, Döring G.

J Biol Chem. 2008 Oct 17;283(42):28629-40. doi: 10.1074/jbc.M801196200. Epub 2008 Aug 11.

30.

Downregulation of p63 upon exposure to bile salts and acid in normal and cancer esophageal cells in culture.

Roman S, Pétré A, Thépot A, Hautefeuille A, Scoazec JY, Mion F, Hainaut P.

Am J Physiol Gastrointest Liver Physiol. 2007 Jul;293(1):G45-53.

31.

[The possibilities for improving the serological diagnosis of active tuberculosis by using new mycobacterial antigens and immunoblot and ELISA technics].

Bănică D, Algeorge G, Moisoiu A, Petre A, Toancă M.

Pneumoftiziologia. 1994 Jul-Dec;43(3-4):173-7. Romanian.

PMID:
7767101
32.
33.

Advantages of treatment with Reprimun in sarcoidosis.

Păunescu E, Didilescu C, Mihălţan F, Udrea S, Serbescu A, Dănălache-Dumitrescu M, Smărăndache M, Stoinescu M, Zaharescu C, Petre A, et al.

Med Interne. 1989 Jul-Sep;27(3):225-8.

PMID:
2617077
34.

[Immune reactivity and immunomodulator-induced changes in bronchopulmonary infections].

Algeorge G, Stoian M, Petre A, Bănică D, Molan M, Bercea O, Morgenstern H.

Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol. 1987 Jan-Mar;36(1):57-66. Romanian. No abstract available.

PMID:
3033801
35.

[Chronic obstructive bronchopneumonia associated with diffuse interstitial fibrosis].

Anastasatu C, Morgenstern H, Duţu S, Păunescu E, Algeorge G, Petre A, Pruteanu L.

Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol. 1985 Jan-Mar;34(1):31-40. Romanian. No abstract available.

PMID:
2990010
36.

[Study of the immune profile in bronchopulmonary cancer and its clinical significance].

Anastasatu C, Morgenstern H, Burnea D, Păunescu E, Algeorge G, Petre A, Pruteanu L.

Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol. 1983 Jan-Mar;32(1):59-68. Romanian. No abstract available.

PMID:
6312537
37.

[Preliminary results of the use of a new derivative of rifamycin SV in the treatment of sarcoidosis].

Păunescu E, Burnea D, Zaharescu C, Stoinescu M, Algeorge G, Petre A, Corlan E, Smărăndache M, Dănălache-Dumitrescu M, Jienescu Z, Oprişiu G.

Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol. 1982 Apr-Jun;31(2):141-50. Romanian.

PMID:
6294806
38.

[Diagnostic and prognostic significance of serum and secretory immunoglobulin levels in chronic pulmonary diseases].

Algeorge G, Petre A, Bănică D, Sibila S, Morgenstern H, Cristea M.

Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol. 1979 Oct-Dec;28(4):229-38. Romanian. No abstract available.

PMID:
232304
39.

[Immunogenetic aspects of the determinism and evolution of chronic obstructive bronchopneumopathy (COBP)].

Anastasatu C, Morgenstern H, Burnea D, Cristea M, Algeorge G, Păunescu E, Bogdănescu V, Petre A.

Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol. 1979 Oct-Dec;28(4):219-27. Romanian. No abstract available.

PMID:
232303
40.

Intermittent rifampicin treatment in experimental tuberculosis.

Algeorge G, Rudescu D, Petre A.

Arch Roum Pathol Exp Microbiol. 1973 Jun;32(2):277-86. No abstract available.

PMID:
4584318
41.

[Experimental study of a biphasic treatment (RMP followed by INH) in tuberculosis in guinea pigs].

Algeorge G, Petre A, Rudescu D.

Ftiziologia. 1973 May-Jun;22(3):295-304. Romanian. No abstract available.

PMID:
4576115
42.

[Fluorescence microscopy in the diagnosis of pulmonary tuberculosis].

Algeorge G, Petre A, Stoian M.

Ftiziologia. 1972 Jul-Aug;21(4):365-78. Romanian. No abstract available.

PMID:
4644563
43.
44.

[Clinical and bacteriological correlations in 90 autopsies of tubercular children].

Lupaşcu I, Algeorge G, Teodosiu-Fierbinţeanu O, Petre A.

Pediatria (Bucur). 1970 Jan-Feb;19(1):57-63. Romanian. No abstract available.

PMID:
4986857
45.

Some experimental aspects of cross-resistance between capreomycin and viomycin.

Algeorge G, Petre A.

Antibiot Chemother. 1970;16:32-5. No abstract available.

PMID:
4108892
46.

On the serologic identifiction of mycobacteria by the fluorescent antibody method.

Algeorge G, Stoian M, Petre A.

Arch Roum Pathol Exp Microbiol. 1969 Jun-Sep;28(2):311-8. No abstract available.

PMID:
4099493
47.

[Contributions to the immune morphology of sensitization. IV. The part played by the dose of the sensitizing antigen in the formation of a pulmonary tissue capable of a secondary reaction].

Eskenasy A, Galbenu P, Petre A.

Z Immunitatsforsch Allerg Klin Immunol. 1968 Apr;135(2):134-45. German. No abstract available.

PMID:
4234993
48.

Contributions to the immunomorphology of sensibilization. 3. Influence of the challenge doses on the intensity of the pulmonary delayed-hypersensitivity reaction.

Eskenasy A, Galbenu P, Petre A.

Z Immunitatsforsch Allerg Klin Immunol. 1968 Mar;135(1):9-18. No abstract available.

PMID:
4234957
49.

[Doctor Juan M. Obarrio died in Buenos Aires on 26 May 1958].

PETRE AJ.

Rev Asoc Med Argent. 1958 May-Jun;72(5-6):173-7. Spanish. No abstract available.

PMID:
13591627

Supplemental Content

Support Center